학술논문
MN03 - A multinational, randomized, double-blind, placebo-controlled Phase 2 study to assess safety and efficacy of olesoxime in Type 2 or non-ambulatory Type 3 spinal muscular atrophy
Document Type
Abstract
Author
Source
In Neuromuscular Disorders March 2017 27 Supplement 1:S29-S29
Subject
Language
ISSN
0960-8966